ArticleCancer medicine2021

Abnormal expression and methylation of PRR34-AS1 are associated with adverse outcomes in acute myeloid leukemia.

Fang-Yu Nan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.